Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

January 25, 2018January 25, 2018

Neurofeedback Training Boosts Brain Connections in Huntington’s, Despite Degeneration

News

Neurofeedback training may increase brain connectivity in patients with Huntington’s disease, possibly improving behavior and movement abnormalities, say British researchers at University College London. Their study, “Stimulating neural plasticity with real-time ... Read more

November 14, 2017

Spanish Study Explains Why Protein Loses Its Ability to Protect Nerve Cells

News

A protein responsible for protecting nerve cells can become embedded in other substances in the brains of Huntington’s patients, preventing it from performing its neuroprotective work, Spanish researchers report. Another ... Read more

October 19, 2017

Molecular Interactions Study May Advance Insight into Huntington’s Disease Processes

News

Researchers have come up with a new method to study the interactions between cell components that are thought to be defective in patients with Huntington’s disease and other neurodegenerative conditions. ... Read more

September 21, 2017September 21, 2017

Huntington’s Patients Would Benefit from More Hospice Involvement, Researchers Argue

News

Less is known about the late stages of Huntington’s disease than about its earlier stages, particularly concerning patients enrolled in hospice care. Researchers studying this patient group recently concluded that ... Read more

August 22, 2017August 22, 2017

Identification of Huntington’s Disease Progression Gene Raises Hope of New Treatments

News

Researchers in England and Wales have identified a gene linked to disease progression in Huntington’s disease, shedding new light on the poorly understood mechanisms that cause the disorder. Although the ... Read more

July 25, 2017

Brain Receptor Caught in Action May Help Researchers Find New Huntington’s Treatments

News

A snapshot of a key brain receptor in action might advance the understanding of disease processes in Huntington’s disease and allow scientists to identify new treatments, researchers at Columbia University ... Read more

July 20, 2017July 20, 2017

New Research Data Network Aims to Advance Discovery of Huntington’s Treatment

News

Researchers have created the first freely available data network — called HDNetDB — that aims to advance research into Huntington’s disease and speed up drug discovery for the incurable condition. ... Read more

June 13, 2017

Researchers Propose NfL as New Blood Marker of Huntington’s Disease Onset, Progression

News

A factor called neurofilament light (NfL) may act as a biomarker of progression in Huntington’s disease, as blood levels of the molecule increase with more severe neurodegeneration. However, the factor ... Read more

June 6, 2017

Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials

News

Voyager Therapeutics has a new candidate for the treatment of Huntington’s disease. The selected gene therapy is called VY-HTT01 and aims to prevent the production of protein from the mutant huntingtin gene ... Read more

May 25, 2017May 25, 2017

Neuroprotective Pathway May Be Key to Understanding Huntington’s Progression

News

A team of researchers has discovered new insights into cell processes that have gone awry in Huntingon’s disease (HD) patients. This discovery could point scientists toward a potential method of ... Read more